Can Innovation Save Healthcare? CEOs From Around The World to Address This Challenge at 'The Global Leaders Healthcare Forum' in San Francisco January 10
SAN FRANCISCO, December 12, 2011, 2011 /PRNewswire/ -- A magazine headline said this week, "Innovation Saves the World." But can innovation save the world's broken healthcare system? This question will be before hundreds of chief executive officers, partners and top executives from many of the world's largest and most progressive companies and investor groups when they meet in San Francisco for the 2(nd) Annual Global Leaders Healthcare Forum on January 10, 2012.
To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/53568-the-global-leaders-healthcare-forum-san-francisco-2011
The executives RSVP'ing from healthcare, biotech and pharmaceutical companies - and their financial investment counterparts - are the right people to have in any room: they represent 25 countries, 50 industries and 500 companies with revenues and assets exceeding $1 trillion. And they'll be probing an urgent proposition facing healthcare: can we bridge the gap between innovation and resources? One panel, moderated by Kathleen Sharp, a contributor to and author of , will take a global view of healthcare and seek candid conclusions about world progress to date. The panel will grapple with a mixed picture, because, despite the enormous obstacles to providing affordable healthcare, on the horizon are remarkable breakthroughs; for example, new systems to help people keep track of all their own medical conditions.
"The biggest issue is getting money and help. The cost of capital for biotech companies is way above the cost for big companies, by a factor of five," said George Bickerstaff, Executive Chairman of The Global Leaders, Partner and Managing Director of M.M. Dillon LLC, and former CFO, Novartis Pharma AG. "We'll be bringing together some of the best and brightest minds in the world to address one of the biggest challenges facing this generation or any to follow."
As Pfizer's Chief Medical Officer, Freda Lewis-Hall, framed the challenge at the recent TedMed Conference, "We need to innovate the innovative model... to get us to the next level."
Another panel will look at "Healthcare Regulatory Changes and the Impact on Innovation, Pricing and Reimbursement in Emerging Healthcare Companies." It takes years to get a new drug approved and can cost upwards of $1 billion to deliver a new drug. What incentives, if any, does the FDA have to help get new treatments to the market? So often, it seems that the FDA pulls drugs off the market without complete explanation.
Other panels will look at efforts to speed up the drug approval process, how to provide incentives to help develop treatments, use of the tax structure to reward companies that take risk for the public good, and use of arbitration rather than litigation.
The Global Leaders is a digital community for CEOs and other senior-level executives in business, government, education and philanthropy. The Global Leaders has 2 million members who have held senior executive leadership positions in companies that drive more than 50 percent of the world's Gross Domestic Product. The January 10 forum will provide a dialogue among industry experts through speeches, panels, interactive table discussions and informal networking. The news media and a battery of health-focused bloggers will be at the forum.
A brochure with details about the forum is at: http://bit.ly/vYoC5w.
To register: http://tglhealthcaresymposium.eventbrite.com/ .
Distinguished speakers at the forum will include: conference co-chair Dr. Margaret Liu, Vice Chairman, International Vaccine Institute; biotech and pharmaceutical pioneer Myrtle Potter, CEO of The Myrtle Potter Company; and Harry Kraemer, Executive Partner, Madison Dearborn. Evening activities include a reception and dinner sponsored by CTPartners and featuring speakers: Dr. Molly Coye, Chief Innovation Officer, UCL Health Systems; John Figueroa, CEO of Omnicare; and Mark Sirangelo, Chairman, Sierra Nevada Space Systems.
Lead sponsors include CTPartners, Epstein Becker & Green, and IDEA Pharma. Other sponsors are CorpShorts, PRNewswire/MultiVu, Robins, Kaplan, Miller & Ciresi, LLP, M.M. Dillon & Co., Elsevier Business Intelligence, M&A Chicago, AVG, LatinVision, The Conference Forum, One Mind for Research, Gershon Capital & Cie, Synergetics, Group 50 Consulting, Remerinc, International Vaccine Institute, and HSM Global.
Follow The Global Leaders on Twitter at @TGLeaders and the Healthcare Forum at #TGLHealth.
Contact: William Adler, Belvedere Communications, 203 438-5085 email@example.com
Posted: December 2011